# Jinkebo

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/jinkebo

- Industry: Biotechnology
- Headquarters: Shanghai, China
- Latest round: Series A (Dec 1, 2025)
- Investors on record: 3

## About

Based in Shanghai, China, and founded in 2021, Shanghai Jinkebo Biotechnology Co., Ltd., trading as Jinkebo is a gene therapy product developer that develops gene therapy research and development platforms, including the construction and optimization of viral vectors, the development of large-scale cell culture and virus production processes, quality control platforms, and preclinical validation. In December 2025, Jinke Biotech raised a series A funding from new investors Zhuhai Longmen Capital Management, Genesis International Equity Investment and Deep Intelligent Pharma.

The company provides gene therapy products.

The company's revenue is generated by providing gene therapy products.

The company will use the latest funding to accelerate the research and development and production of gene therapy products.

## Funding rounds

- Series A, Dec 1, 2025 — Zhuhai Longmen Capital Management, Deep Intelligent Pharma, Genesis International Equity Investment

## Investors

- Zhuhai Longmen Capital Management (https://capitalatlas.ai/funds/zhuhai-longmen-capital-management) — Series A
- Deep Intelligent Pharma — Series A
- Genesis International Equity Investment (https://capitalatlas.ai/funds/genesis-international-equity-investment) — Series A